Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nicole R. Villemarette-Pittman"'
Publikováno v:
eNeurologicalSci, Vol 30, Iss , Pp 100445- (2023)
Background: Autonomic dysfunction including sudomotor abnormalities have been reported in association with SARS-CoV-2 infection. Objective: There are no previous studies that have compared autonomic function objectively in patients pre- and post- SAR
Externí odkaz:
https://doaj.org/article/142809e1827347b486b69b86785d0570
Publikováno v:
eNeurologicalSci, Vol 23, Iss , Pp 100339- (2021)
Magnetic resonance guided focused ultrasound (MRgFUS) thalamotomy targets the ventral intermediate nucleus of the thalamus and has been shown to be safe and effective to treat medication-resistant essential tremors. Improvement in tremor scores, post
Externí odkaz:
https://doaj.org/article/b724f51c57a0454babced93c968bf994
Autor:
David Chachkhiani, Michael Y. Soliman, Delphi Barua, Marine Isakadze, Nicole R. Villemarette-Pittman, Deidre J. Devier, Jesus F. Lovera
Publikováno v:
Data in Brief, Vol 35, Iss , Pp 106944- (2021)
We reviewed the electronic medical records (EMR) of patients hospitalized during the peak of the pandemic, March 1st through March 31st, to document the type and frequency of neurological problems seen in patients with COVID-19 at presentation to the
Externí odkaz:
https://doaj.org/article/2154874202c84e338f9767ed9c79341b
Autor:
Alexander B. Ramos MD, MS, Roberto A. Cruz MD, Nicole R. Villemarette-Pittman PhD, Piotr W. Olejniczak MD, PhD, Edward C. Mader MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 7 (2019)
Refractory seizures or status epilepticus (RS/SE) continues to be a challenge in the inpatient setting. Failure to abort a seizure with antiepileptic drugs (AEDs) may lead to intubation and treatment with general anesthesia exposing patients to compl
Externí odkaz:
https://doaj.org/article/c1294c86f42d40aaaf3792cad3abf133
Autor:
Edward C. Mader Jr, Nicole R. Villemarette-Pittman, Sergei V. Kashirny, Lenay Santana-Gould, Piotr W. Olejniczak
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 2012, Iss 5, Pp 99-106 (2012)
Externí odkaz:
https://doaj.org/article/dbcf718ff0bb483fae6a37ed32c4d307
Autor:
Edward C. Mader Jr., Nicole R. Villemarette-Pittman, Cornel T. Rogers, Frank Torres-Delgado, Piotr W. Olejniczak, John D. England
Publikováno v:
Neurology International, Vol 6, Iss 3 (2014)
Burst suppression (BS) consists of bursts of high-voltage slow and sharp wave activity alternating with periods of background suppression in the electroencephalogram (EEG). When induced by deep anesthesia or encephalopathy, BS is bihemispheric and is
Externí odkaz:
https://doaj.org/article/e68491bd8d354987845fd772ac07a249
Autor:
Edward C. Mader, Rima El-Abassi, Nicole R. Villemarette-Pittman, Lenay Santana-Gould, Piotr W. Olejniczak, John D. England
Publikováno v:
Neurology International, Vol 5, Iss 1, Pp e1-e1 (2013)
The clinical diagnosis of Creutzfeldt-Jakob disease (CJD) is largely based on the 1998 World Health Organization diagnostic criteria. Unfortunately, rigid compliance with these criteria may result in failure to recognize sporadic CJD (sCJD), especial
Externí odkaz:
https://doaj.org/article/86b7812e503a452daa1ae95da029826f
Autor:
Edward C. Mader, Bruce J. Fisch, Nicole R. Villemarette-Pittman, Piotr W. Olejniczak, Michael E. Carey
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Intractable epilepsy with painful partial motor seizures is a relatively rare and difficult disorder to treat. We evaluated the usefulness of botulinum toxin to reduce ictal pain. Two patients received two or four botulinum toxin (BTX) injections at
Externí odkaz:
https://doaj.org/article/371f61edd8ab4269a89052cd7b100992
Autor:
Michael Y. Soliman, Delphi Barua, Marine Isakadze, Deidre J. Devier, David Chachkhiani, Nicole R. Villemarette-Pittman, Jesus Lovera
Publikováno v:
Data in Brief, Vol 35, Iss, Pp 106944-(2021)
Data in Brief
Data in Brief
We reviewed the electronic medical records (EMR) of patients hospitalized during the peak of the pandemic, March 1st through March 31st, to document the type and frequency of neurological problems seen in patients with COVID-19 at presentation to the